chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Discomfort, Lymph node pain, Pain, Swelling
Clinical narrative: pain by my ear on my face/  lymph node; throbbing pain; swelling; experiencing discomfort; This is a spontaneous report from a contactable consumer (patient reported herself). A 58-Year-old non-pregnant female patient received second dose of BNT162B2 (COVID 19, Pfizer, Solution for injection) via an unspecified route of administration to her right arm on 19Feb2021 02:30 PM (Lot number: EN 6201) as single dose for Covid-19 immunization. The patient's medical history was not reported. Concomitant medications were reported as none. She was allergic to celecoxib (CELEBREX) (Known allergies: Celebrex). Other medical history was none. Facility type vaccine: Other. The patient previously took first dose of BNT162B2 (COVID 19, Pfizer) to her right arm on 29Jan2021 02:30 PM as single dose for Covid-19 immunization. Other medications in two weeks was reported none. It was reported that, on 19Feb2021 05:00 PM, three hours after receiving the second vaccine experienced pain by ear on face. With a little research she found out there was a lymph node called preauricular. She had throbbing pain and swelling. It was been three days since Covid shot and still experiencing discomfort. No Covid tested prior/post vaccination. The patient did not receive any treatment in response to the events. Outcome of the events was not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Rash, Rash erythematous
Clinical narrative: rash; This is a spontaneous report from a contactable consumer. A 79-years-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 10Feb2021 (Batch/Lot Number: el9269) as SINGLE DOSE for covid-19 immunization. The medical history of patient included vascular disease, chronic lymphocytic leukemia, squamous cell. The concomitant medications included Atorvastatin, Metoprolol, multivitamin, low dose As. The patient previously took amoxicillin and experienced drug hypersensitivity, doxycycline and experienced drug hypersensitivity. Patient's historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) (Batch/LOT no el3294) dose 1 on 20Jan2021 at 10:30 via an unknown route of administration in left arm as single dose for COVID-19 immunisation. On 13Feb2021, the patient had rash that appeared about 4 inches in diameter and continued to enlarge around arm above elbow and on the inside of arm down to watch band through 20Feb2021. Patient did not receive any treatment. Patient did not have covid prior vaccination. Patient did not have covid tested post vaccination. The outcome of the event was recovered on 24Feb2021.
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Rash
Clinical narrative: rash; This is a spontaneous report from a contactable consumer. A 79-years-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 10Feb2021 (Batch/Lot Number: el9269) as SINGLE DOSE for covid-19 immunization. The medical history of patient included vascular disease, chronic lymphocytic leukemia, squamous cell. The concomitant medications included Atorvastatin, Metoprolol, multivitamin, low dose As. The patient previously took amoxicillin and experienced drug hypersensitivity, doxycycline and experienced drug hypersensitivity. Patient's historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) (Batch/LOT no el3294) dose 1 on 20Jan2021 at 10:30 via an unknown route of administration in left arm as single dose for COVID-19 immunisation. On 13Feb2021, the patient had rash that appeared about 4 inches in diameter and continued to enlarge around arm above elbow and on the inside of arm down to watch band through 20Feb2021. Patient did not receive any treatment. Patient did not have covid prior vaccination. Patient did not have covid tested post vaccination. The outcome of the event was recovered on 24Feb2021.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Pruritus
Clinical narrative: broke out in rash with intense itching on arms, neck, head, chest, torso.; Some swelling in neck and face.; Some swelling in neck and face.; This is a spontaneous report received from a contactable consumer or other non hcp. A 69-years-old non pregnant female patient received first dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EN6201), via an unspecified route of administration, administered in Arm Left on 24Feb2021 on 13:00 as single dose for COVID-19 immunization.The patient did not receive any other vaccines within 4 weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Medical history included cardiac disorder, chronic obstructive pulmonary disease, asthma, diabetes mellitus, osteoporosis, arthritis, allergy to arthropod sting and drug hypersensitivity. Concomitant medications included metformin, simvastatin, montelukast and candesartan taken for an unspecified indication, start and stop date were not reported. The patient previously took vancomycin, sulfa, wasp stings and tetracycline and therefore experienced drug hypersensitivity. On 24Feb2021 at 13:30 patient experienced broke out in rash with intense itching on arms, neck, head, chest, torso and some swelling in neck and face (swelling and swelling face). As treatment was done by Benadryl, epi pen, Famotidine, Solu-Medrol and Prednisolone. The outcome of the events was recovering.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash, Swelling, Swelling face
Clinical narrative: broke out in rash with intense itching on arms, neck, head, chest, torso.; Some swelling in neck and face.; Some swelling in neck and face.; This is a spontaneous report received from a contactable consumer or other non hcp. A 69-years-old non pregnant female patient received first dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EN6201), via an unspecified route of administration, administered in Arm Left on 24Feb2021 on 13:00 as single dose for COVID-19 immunization.The patient did not receive any other vaccines within 4 weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Medical history included cardiac disorder, chronic obstructive pulmonary disease, asthma, diabetes mellitus, osteoporosis, arthritis, allergy to arthropod sting and drug hypersensitivity. Concomitant medications included metformin, simvastatin, montelukast and candesartan taken for an unspecified indication, start and stop date were not reported. The patient previously took vancomycin, sulfa, wasp stings and tetracycline and therefore experienced drug hypersensitivity. On 24Feb2021 at 13:30 patient experienced broke out in rash with intense itching on arms, neck, head, chest, torso and some swelling in neck and face (swelling and swelling face). As treatment was done by Benadryl, epi pen, Famotidine, Solu-Medrol and Prednisolone. The outcome of the events was recovering.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia oral, Paraesthesia, Pruritus
Clinical narrative: minor allergic reaction; This is a spontaneous report from a contactable consumer (patient himself). A 71-year-old male patient received first dose of BNT162B2 (PFIZER BIONTECH COVID mRNA VACCINE, solution for injection, lot number: EN 6198) via an unspecified route of administration in right arm on 24Feb2021 at 10:45 (at the age of 71-year-old) as single dose for COVID-19 immunization. The patient medical history included High cholesterol and known allergies included Bee stings. The patient had no other vaccine in four weeks. Concomitant medication took in two weeks included simvastatin (SIMVASTATIN) dose of 10 mg on an unspecified date. On 24Feb2021 at 11:15, the patient experienced minor allergic reaction Face tingling, itchy right palm and Lips going numb. The patient not had covid prior vaccination; not tested covid post vaccination. The patient did not receive any treatment for the events. The outcome of the events was recovered on an unspecified date.  No follow-up attempts are possible. No further information is expected.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypersensitivity
Clinical narrative: minor allergic reaction; This is a spontaneous report from a contactable consumer (patient himself). A 71-year-old male patient received first dose of BNT162B2 (PFIZER BIONTECH COVID mRNA VACCINE, solution for injection, lot number: EN 6198) via an unspecified route of administration in right arm on 24Feb2021 at 10:45 (at the age of 71-year-old) as single dose for COVID-19 immunization. The patient medical history included High cholesterol and known allergies included Bee stings. The patient had no other vaccine in four weeks. Concomitant medication took in two weeks included simvastatin (SIMVASTATIN) dose of 10 mg on an unspecified date. On 24Feb2021 at 11:15, the patient experienced minor allergic reaction Face tingling, itchy right palm and Lips going numb. The patient not had covid prior vaccination; not tested covid post vaccination. The patient did not receive any treatment for the events. The outcome of the events was recovered on an unspecified date.  No follow-up attempts are possible. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chills, Headache, Influenza like illness, Injection site pain
Clinical narrative: injection site tenderness; severe headache with vision changes; severe headache with vision changes; pronounced joint and muscle pain; pronounced joint and muscle pain; chills; feeling very ill - flu like but without fever or congestion/cough; feeling very ill - flu like but without fever or congestion/cough; This is a spontaneous report from a contactable consumer (patient). A 68-years-old female patient received first dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EL9267), via an unspecified route of administration, administered in arm left on 22Feb2021 at 14:00 as single dose for COVID-19 immunization. Medical history included COVID-19 from an unknown date and unknown if ongoing as COVID was seen prior to vaccination. hypertension, GERD, osteopenia, mild arthritis, high cholesterol, depression. Also reported known allergies such as latex, thyroid scan uptake medium, KIWI, food allergy. Concomitant medications included HCTZ, amlodipine besilate; enalapril, omeprazole, duloxetine hydrochloride and gabapentin for an unspecified indication. On 23Feb2021 at 17:30 patient reported injection site tenderness, severe headache with vision changes, severe headache with vision changes, pronounced joint and muscle pain, chills and feeling very ill - flu like but without fever or congestion/cough. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Malaise, Myalgia, Vision blurred, Visual impairment
Clinical narrative: injection site tenderness; severe headache with vision changes; severe headache with vision changes; pronounced joint and muscle pain; pronounced joint and muscle pain; chills; feeling very ill - flu like but without fever or congestion/cough; feeling very ill - flu like but without fever or congestion/cough; This is a spontaneous report from a contactable consumer (patient). A 68-years-old female patient received first dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EL9267), via an unspecified route of administration, administered in arm left on 22Feb2021 at 14:00 as single dose for COVID-19 immunization. Medical history included COVID-19 from an unknown date and unknown if ongoing as COVID was seen prior to vaccination. hypertension, GERD, osteopenia, mild arthritis, high cholesterol, depression. Also reported known allergies such as latex, thyroid scan uptake medium, KIWI, food allergy. Concomitant medications included HCTZ, amlodipine besilate; enalapril, omeprazole, duloxetine hydrochloride and gabapentin for an unspecified indication. On 23Feb2021 at 17:30 patient reported injection site tenderness, severe headache with vision changes, severe headache with vision changes, pronounced joint and muscle pain, chills and feeling very ill - flu like but without fever or congestion/cough. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Malaise, Myalgia, Visual impairment
Clinical narrative: injection site tenderness; severe headache with vision changes; severe headache with vision changes; pronounced joint and muscle pain; pronounced joint and muscle pain; chills; feeling very ill - flu like but without fever or congestion/cough; feeling very ill - flu like but without fever or congestion/cough; This is a spontaneous report from a contactable consumer (patient). A 68-years-old female patient received first dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EL9267), via an unspecified route of administration, administered in arm left on 22Feb2021 at 14:00 as single dose for COVID-19 immunization. Medical history included COVID-19 from an unknown date and unknown if ongoing as COVID was seen prior to vaccination. hypertension, GERD, osteopenia, mild arthritis, high cholesterol, depression. Also reported known allergies such as latex, thyroid scan uptake medium, KIWI, food allergy. Concomitant medications included HCTZ, amlodipine besilate; enalapril, omeprazole, duloxetine hydrochloride and gabapentin for an unspecified indication. On 23Feb2021 at 17:30 patient reported injection site tenderness, severe headache with vision changes, severe headache with vision changes, pronounced joint and muscle pain, chills and feeling very ill - flu like but without fever or congestion/cough. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature fluctuation, Dizziness, Fatigue, Frequent bowel movements, Hot flush
Clinical narrative: intermittent lightheadedness; migrating sensation of tingling over body & face; bowel urgency; warm flush; though very fatigued; coldness of feet, then hands; This is a spontaneous report received from a contactable Other-Health Care Professional (patient). A 57-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VAC-CINE, Formulation: solution for injection, lot number: EN6201 and Expiry date was not reported), via an unspecified route of administration in left arm on 20Feb2021 as single dose for COVID-19 immunization. The patient medical history included Hypothyroid, Hypertension, Menopause and Shrimp allergy were reported. The patient concomitant medications Synthroid, Telmisartan/HCTZ, Prempro were reported. No other vaccination in four weeks. Patient did not have covid prior vac-cination. On 20Feb2021 Immediate post vaccination onset of intermittent lightheadedness and mi-grating sensation of tingling over body & face; at 45 minutes also experienced a sequence of cold-ness of feet, then hands (w/decreased perfusion), as those resolved then core/trunk, as trunk warmed then at 75 min upper gums, then eyelids, then nose; bowel urgency; at 2 hours warm flush, mind clearer, better color vision, feeling stronger; lightheadedness resolved within 3 hours of pharmacist observation. No urticaria, angioedema or respiratory distress. No treatment. Could stand and walk with assistance, though very fatigued. Rested at home. Re-presentation of light-headedness & tingling on 22Feb & again mildly on 24Feb while resting. Patient did not receive any treatment for adverse event. Patient did not tested covid post vaccination. The outcome for event peripheral coldness was recovered and for events dizziness, paraesthesia, Anal incontinence, Hot flush, Fatigue was recovering.  No follow-up attempts are possible; No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Immediate post-injection reaction, Peripheral coldness
Clinical narrative: intermittent lightheadedness; migrating sensation of tingling over body & face; bowel urgency; warm flush; though very fatigued; coldness of feet, then hands; This is a spontaneous report received from a contactable Other-Health Care Professional (patient). A 57-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VAC-CINE, Formulation: solution for injection, lot number: EN6201 and Expiry date was not reported), via an unspecified route of administration in left arm on 20Feb2021 as single dose for COVID-19 immunization. The patient medical history included Hypothyroid, Hypertension, Menopause and Shrimp allergy were reported. The patient concomitant medications Synthroid, Telmisartan/HCTZ, Prempro were reported. No other vaccination in four weeks. Patient did not have covid prior vac-cination. On 20Feb2021 Immediate post vaccination onset of intermittent lightheadedness and mi-grating sensation of tingling over body & face; at 45 minutes also experienced a sequence of cold-ness of feet, then hands (w/decreased perfusion), as those resolved then core/trunk, as trunk warmed then at 75 min upper gums, then eyelids, then nose; bowel urgency; at 2 hours warm flush, mind clearer, better color vision, feeling stronger; lightheadedness resolved within 3 hours of pharmacist observation. No urticaria, angioedema or respiratory distress. No treatment. Could stand and walk with assistance, though very fatigued. Rested at home. Re-presentation of light-headedness & tingling on 22Feb & again mildly on 24Feb while resting. Patient did not receive any treatment for adverse event. Patient did not tested covid post vaccination. The outcome for event peripheral coldness was recovered and for events dizziness, paraesthesia, Anal incontinence, Hot flush, Fatigue was recovering.  No follow-up attempts are possible; No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anal incontinence, Dizziness, Fatigue, Hot flush, Paraesthesia
Clinical narrative: intermittent lightheadedness; migrating sensation of tingling over body & face; bowel urgency; warm flush; though very fatigued; coldness of feet, then hands; This is a spontaneous report received from a contactable Other-Health Care Professional (patient). A 57-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VAC-CINE, Formulation: solution for injection, lot number: EN6201 and Expiry date was not reported), via an unspecified route of administration in left arm on 20Feb2021 as single dose for COVID-19 immunization. The patient medical history included Hypothyroid, Hypertension, Menopause and Shrimp allergy were reported. The patient concomitant medications Synthroid, Telmisartan/HCTZ, Prempro were reported. No other vaccination in four weeks. Patient did not have covid prior vac-cination. On 20Feb2021 Immediate post vaccination onset of intermittent lightheadedness and mi-grating sensation of tingling over body & face; at 45 minutes also experienced a sequence of cold-ness of feet, then hands (w/decreased perfusion), as those resolved then core/trunk, as trunk warmed then at 75 min upper gums, then eyelids, then nose; bowel urgency; at 2 hours warm flush, mind clearer, better color vision, feeling stronger; lightheadedness resolved within 3 hours of pharmacist observation. No urticaria, angioedema or respiratory distress. No treatment. Could stand and walk with assistance, though very fatigued. Rested at home. Re-presentation of light-headedness & tingling on 22Feb & again mildly on 24Feb while resting. Patient did not receive any treatment for adverse event. Patient did not tested covid post vaccination. The outcome for event peripheral coldness was recovered and for events dizziness, paraesthesia, Anal incontinence, Hot flush, Fatigue was recovering.  No follow-up attempts are possible; No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Peripheral coldness
Clinical narrative: intermittent lightheadedness; migrating sensation of tingling over body & face; bowel urgency; warm flush; though very fatigued; coldness of feet, then hands; This is a spontaneous report received from a contactable Other-Health Care Professional (patient). A 57-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VAC-CINE, Formulation: solution for injection, lot number: EN6201 and Expiry date was not reported), via an unspecified route of administration in left arm on 20Feb2021 as single dose for COVID-19 immunization. The patient medical history included Hypothyroid, Hypertension, Menopause and Shrimp allergy were reported. The patient concomitant medications Synthroid, Telmisartan/HCTZ, Prempro were reported. No other vaccination in four weeks. Patient did not have covid prior vac-cination. On 20Feb2021 Immediate post vaccination onset of intermittent lightheadedness and mi-grating sensation of tingling over body & face; at 45 minutes also experienced a sequence of cold-ness of feet, then hands (w/decreased perfusion), as those resolved then core/trunk, as trunk warmed then at 75 min upper gums, then eyelids, then nose; bowel urgency; at 2 hours warm flush, mind clearer, better color vision, feeling stronger; lightheadedness resolved within 3 hours of pharmacist observation. No urticaria, angioedema or respiratory distress. No treatment. Could stand and walk with assistance, though very fatigued. Rested at home. Re-presentation of light-headedness & tingling on 22Feb & again mildly on 24Feb while resting. Patient did not receive any treatment for adverse event. Patient did not tested covid post vaccination. The outcome for event peripheral coldness was recovered and for events dizziness, paraesthesia, Anal incontinence, Hot flush, Fatigue was recovering.  No follow-up attempts are possible; No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chills, Decreased appetite, Fatigue, Myalgia
Clinical narrative: Fatigue; Loss of appetite; Taste buds were off; Chills; Muscle ache; Severe joint pain; This is a spontaneous report from a contactable consumer (Patient). A 67-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Left Arm on 24Feb2021 (Batch/Lot Number: EN6198) as SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. Concomitant medication(s) included calcium citrate, colecalciferol (CITRACAL; CALCIUM CITRATE; COLECALCIFEROL) taken for an unspecified indication, start and stop date were not reported. Historical Vaccine included (dose: 1) BNT162B2 for covid-19 immunisation. The patient experienced chills on 24Feb2021, muscle ache on 24Feb2021, severe joint pain on 24Feb2021, fatigue on 25Feb2021, loss of appetite on 25Feb2021, taste buds were off on 25Feb2021; all (non-serious). It was reported that Patient History: No. Investigation Assessment: No. Consumer stated, "I had some side effects from the COVID 19 Vaccine." When probed if consumer wanted to report this or have some questions, consumer stated, "I was going to report them." When probed for the side effects, Consumer stated, "I had the evening or the night of the vaccine, I had a chills, muscle aches, and severe joint pains. And the following day I had fatigue and loss of appetite and my taste buds were off." Dose: Consumer stated, "It's the second dose." Anatomical location of Vaccination: Left arm. Other medical conditions: No, the only other thing I am taking is Citracal Calcium Vitamin D (further not clarified)." Event details: Start date: Consumer stated, "24Feb2021 for Chills, muscle ache, and severe joint pain and 25Feb2021 for Fatigue and loss of appetite." Still experiencing: Consumer stated, "Just very mildly." Treatment: Consumer stated, "No I did not." When probed for any other help, Consumer stated, "Just out of curiosity is it, I have heard that if you do have the side effects, do not take pain relievers? Is that correct?". For all events, outcome was recovering.    No follow-up attempts are possible. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Taste disorder
Clinical narrative: Fatigue; Loss of appetite; Taste buds were off; Chills; Muscle ache; Severe joint pain; This is a spontaneous report from a contactable consumer (Patient). A 67-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Left Arm on 24Feb2021 (Batch/Lot Number: EN6198) as SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. Concomitant medication(s) included calcium citrate, colecalciferol (CITRACAL; CALCIUM CITRATE; COLECALCIFEROL) taken for an unspecified indication, start and stop date were not reported. Historical Vaccine included (dose: 1) BNT162B2 for covid-19 immunisation. The patient experienced chills on 24Feb2021, muscle ache on 24Feb2021, severe joint pain on 24Feb2021, fatigue on 25Feb2021, loss of appetite on 25Feb2021, taste buds were off on 25Feb2021; all (non-serious). It was reported that Patient History: No. Investigation Assessment: No. Consumer stated, "I had some side effects from the COVID 19 Vaccine." When probed if consumer wanted to report this or have some questions, consumer stated, "I was going to report them." When probed for the side effects, Consumer stated, "I had the evening or the night of the vaccine, I had a chills, muscle aches, and severe joint pains. And the following day I had fatigue and loss of appetite and my taste buds were off." Dose: Consumer stated, "It's the second dose." Anatomical location of Vaccination: Left arm. Other medical conditions: No, the only other thing I am taking is Citracal Calcium Vitamin D (further not clarified)." Event details: Start date: Consumer stated, "24Feb2021 for Chills, muscle ache, and severe joint pain and 25Feb2021 for Fatigue and loss of appetite." Still experiencing: Consumer stated, "Just very mildly." Treatment: Consumer stated, "No I did not." When probed for any other help, Consumer stated, "Just out of curiosity is it, I have heard that if you do have the side effects, do not take pain relievers? Is that correct?". For all events, outcome was recovering.    No follow-up attempts are possible. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ageusia, Arthralgia, Chills, Decreased appetite, Fatigue
Clinical narrative: Fatigue; Loss of appetite; Taste buds were off; Chills; Muscle ache; Severe joint pain; This is a spontaneous report from a contactable consumer (Patient). A 67-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Left Arm on 24Feb2021 (Batch/Lot Number: EN6198) as SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. Concomitant medication(s) included calcium citrate, colecalciferol (CITRACAL; CALCIUM CITRATE; COLECALCIFEROL) taken for an unspecified indication, start and stop date were not reported. Historical Vaccine included (dose: 1) BNT162B2 for covid-19 immunisation. The patient experienced chills on 24Feb2021, muscle ache on 24Feb2021, severe joint pain on 24Feb2021, fatigue on 25Feb2021, loss of appetite on 25Feb2021, taste buds were off on 25Feb2021; all (non-serious). It was reported that Patient History: No. Investigation Assessment: No. Consumer stated, "I had some side effects from the COVID 19 Vaccine." When probed if consumer wanted to report this or have some questions, consumer stated, "I was going to report them." When probed for the side effects, Consumer stated, "I had the evening or the night of the vaccine, I had a chills, muscle aches, and severe joint pains. And the following day I had fatigue and loss of appetite and my taste buds were off." Dose: Consumer stated, "It's the second dose." Anatomical location of Vaccination: Left arm. Other medical conditions: No, the only other thing I am taking is Citracal Calcium Vitamin D (further not clarified)." Event details: Start date: Consumer stated, "24Feb2021 for Chills, muscle ache, and severe joint pain and 25Feb2021 for Fatigue and loss of appetite." Still experiencing: Consumer stated, "Just very mildly." Treatment: Consumer stated, "No I did not." When probed for any other help, Consumer stated, "Just out of curiosity is it, I have heard that if you do have the side effects, do not take pain relievers? Is that correct?". For all events, outcome was recovering.    No follow-up attempts are possible. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myalgia
Clinical narrative: Fatigue; Loss of appetite; Taste buds were off; Chills; Muscle ache; Severe joint pain; This is a spontaneous report from a contactable consumer (Patient). A 67-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Left Arm on 24Feb2021 (Batch/Lot Number: EN6198) as SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. Concomitant medication(s) included calcium citrate, colecalciferol (CITRACAL; CALCIUM CITRATE; COLECALCIFEROL) taken for an unspecified indication, start and stop date were not reported. Historical Vaccine included (dose: 1) BNT162B2 for covid-19 immunisation. The patient experienced chills on 24Feb2021, muscle ache on 24Feb2021, severe joint pain on 24Feb2021, fatigue on 25Feb2021, loss of appetite on 25Feb2021, taste buds were off on 25Feb2021; all (non-serious). It was reported that Patient History: No. Investigation Assessment: No. Consumer stated, "I had some side effects from the COVID 19 Vaccine." When probed if consumer wanted to report this or have some questions, consumer stated, "I was going to report them." When probed for the side effects, Consumer stated, "I had the evening or the night of the vaccine, I had a chills, muscle aches, and severe joint pains. And the following day I had fatigue and loss of appetite and my taste buds were off." Dose: Consumer stated, "It's the second dose." Anatomical location of Vaccination: Left arm. Other medical conditions: No, the only other thing I am taking is Citracal Calcium Vitamin D (further not clarified)." Event details: Start date: Consumer stated, "24Feb2021 for Chills, muscle ache, and severe joint pain and 25Feb2021 for Fatigue and loss of appetite." Still experiencing: Consumer stated, "Just very mildly." Treatment: Consumer stated, "No I did not." When probed for any other help, Consumer stated, "Just out of curiosity is it, I have heard that if you do have the side effects, do not take pain relievers? Is that correct?". For all events, outcome was recovering.    No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Back pain, Ear pain, Facial pain, Head discomfort
Clinical narrative: pressure headache,Splitting headache; neck ache; shoulders ache; Fever; joints aches; eyes ache; nausea; chills; This is a spontaneous report from a contactable consumer (Patient). A 72-years-old non- pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot/Batch number: EL9266) via an unspecified route of administration, administered in left arm on 18Feb2021 at 10:00 as single dose for covid-19 immunisation. Known allergies included many medications and foods. Patient medical history scoliosis, osteoarthritis, barrett's esophagus. No other vaccine in four weeks. Concomitant medication included vitamin D, alprazolam, dicyclomine. No covid prior vaccination. No covid tested post vaccination. On 18Feb2021 at 10:00 AM, splitting headache, neck ache, shoulders ache, fever, joints aches, eyes ache, pressure headache, nausea, chills. The events assessed as non-serious. No treatment received. The events outcome was not recovered.  No follow up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Mobility decreased, Neck pain, Pyrexia
Clinical narrative: pressure headache,Splitting headache; neck ache; shoulders ache; Fever; joints aches; eyes ache; nausea; chills; This is a spontaneous report from a contactable consumer (Patient). A 72-years-old non- pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot/Batch number: EL9266) via an unspecified route of administration, administered in left arm on 18Feb2021 at 10:00 as single dose for covid-19 immunisation. Known allergies included many medications and foods. Patient medical history scoliosis, osteoarthritis, barrett's esophagus. No other vaccine in four weeks. Concomitant medication included vitamin D, alprazolam, dicyclomine. No covid prior vaccination. No covid tested post vaccination. On 18Feb2021 at 10:00 AM, splitting headache, neck ache, shoulders ache, fever, joints aches, eyes ache, pressure headache, nausea, chills. The events assessed as non-serious. No treatment received. The events outcome was not recovered.  No follow up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chills, Eye pain, Headache, Nausea
Clinical narrative: pressure headache,Splitting headache; neck ache; shoulders ache; Fever; joints aches; eyes ache; nausea; chills; This is a spontaneous report from a contactable consumer (Patient). A 72-years-old non- pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot/Batch number: EL9266) via an unspecified route of administration, administered in left arm on 18Feb2021 at 10:00 as single dose for covid-19 immunisation. Known allergies included many medications and foods. Patient medical history scoliosis, osteoarthritis, barrett's esophagus. No other vaccine in four weeks. Concomitant medication included vitamin D, alprazolam, dicyclomine. No covid prior vaccination. No covid tested post vaccination. On 18Feb2021 at 10:00 AM, splitting headache, neck ache, shoulders ache, fever, joints aches, eyes ache, pressure headache, nausea, chills. The events assessed as non-serious. No treatment received. The events outcome was not recovered.  No follow up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Neck pain, Pyrexia
Clinical narrative: pressure headache,Splitting headache; neck ache; shoulders ache; Fever; joints aches; eyes ache; nausea; chills; This is a spontaneous report from a contactable consumer (Patient). A 72-years-old non- pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot/Batch number: EL9266) via an unspecified route of administration, administered in left arm on 18Feb2021 at 10:00 as single dose for covid-19 immunisation. Known allergies included many medications and foods. Patient medical history scoliosis, osteoarthritis, barrett's esophagus. No other vaccine in four weeks. Concomitant medication included vitamin D, alprazolam, dicyclomine. No covid prior vaccination. No covid tested post vaccination. On 18Feb2021 at 10:00 AM, splitting headache, neck ache, shoulders ache, fever, joints aches, eyes ache, pressure headache, nausea, chills. The events assessed as non-serious. No treatment received. The events outcome was not recovered.  No follow up attempts are possible. No further information is expected.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Discomfort, Pain in extremity, Peripheral swelling
Clinical narrative: I started feeling discomfort from my fracture. By 36 hours I had great discomfort; pain with some swelling.; pain with some swelling.; This is a spontaneous report from a contactable consumer (patient). A 70-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6202), second dose via an unspecified route of administration, administered in right arm on 25Feb2021 07:45 as single dose for covid-19 immunization. The patient was 70 years old at the time of vaccination. Medical history included osteoarthritis and on 27 Jan2021 patient fell and have displace fragment of the 5th metacarpal base. Patient had no known allergies. On 04Feb2021 at 8:00 am patient received first dose of Bnt162b2 (lot number EL9265) in right arm. The patient was not test positive for Covid prior to or post vaccination. Concomitant medications included ROSUVASTATIN, FAMOTIDINE, AMLODIPINE BESYLATE and losartan potassium (LO), all taken on unspecified date and unknown if ongoing. On 26Feb2021 about 34 hours after the shot on 25Feb, the patient started feeling discomfort from his fracture. By 36 hours he had great discomfort and pain with some swelling. More pain than with the original fracture /fall. Talked with OSU vaccine hotline at around 36 hours after shot. They advised he talk with Doctor. He called doctor and was advised elevation, two ibuprofen and on Tylenol every 4 to 6 hours. He did that and after 57 hours out from shot, extreme pain gone, have swelling and some discomfort. Not yet to pre-shot levels of comfort but great improvement. Only took two rounds of ibuprofen and Tylenol. Outcome of the events was recovering.   No follow-up attempts are possible. No further information is expected.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Discomfort, Pain, Swelling
Clinical narrative: I started feeling discomfort from my fracture. By 36 hours I had great discomfort; pain with some swelling.; pain with some swelling.; This is a spontaneous report from a contactable consumer (patient). A 70-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6202), second dose via an unspecified route of administration, administered in right arm on 25Feb2021 07:45 as single dose for covid-19 immunization. The patient was 70 years old at the time of vaccination. Medical history included osteoarthritis and on 27 Jan2021 patient fell and have displace fragment of the 5th metacarpal base. Patient had no known allergies. On 04Feb2021 at 8:00 am patient received first dose of Bnt162b2 (lot number EL9265) in right arm. The patient was not test positive for Covid prior to or post vaccination. Concomitant medications included ROSUVASTATIN, FAMOTIDINE, AMLODIPINE BESYLATE and losartan potassium (LO), all taken on unspecified date and unknown if ongoing. On 26Feb2021 about 34 hours after the shot on 25Feb, the patient started feeling discomfort from his fracture. By 36 hours he had great discomfort and pain with some swelling. More pain than with the original fracture /fall. Talked with OSU vaccine hotline at around 36 hours after shot. They advised he talk with Doctor. He called doctor and was advised elevation, two ibuprofen and on Tylenol every 4 to 6 hours. He did that and after 57 hours out from shot, extreme pain gone, have swelling and some discomfort. Not yet to pre-shot levels of comfort but great improvement. Only took two rounds of ibuprofen and Tylenol. Outcome of the events was recovering.   No follow-up attempts are possible. No further information is expected.
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Joint swelling, Peripheral swelling
Clinical narrative: my left elbow and forearm began to swell into a large ball shape near the elbow joint; my left hand became noticeably swollen as well; Swelling of the armpit, elbow and forearm areas; Swelling of the armpit, elbow and forearm areas; This is a spontaneous report from a contactable consumer. A 74-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: env201), via an unspecified route of administration, administered at left arm, on 24Feb2021 11:00 AM at single dose for COVID-19 immunisation. Patient medical history included allergies to sulfa based drugs. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included Amlodipine - 10mg. The patient stated that no prior reactions to the annual flu, pneumonia, or shingles vaccinations. Because of a scheduled prostate biopsy in early Apr2021, I wanted to complete the vaccination for COVID-19 in advance of this procedure. On 24Feb2021, within 5 mins of receiving the vaccination shot in my left arm, my left elbow and forearm began to swell into a large ball shape near the elbow joint. At the same time, patient's left hand became noticeably swollen as well. Fortunately, Patient did not experience trouble breathing or have any numbness in fingers at that time. The observation staff nurses took patient to a separate room to check blood pressure and heart rate which were both in the normal range. The patient also experienced swelling of the armpit, elbow and forearm areas are still present the next day. The patient received the treatment as Benadryl in response to the adverse events reduce swelling. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. The outcome for events was not recovered. No follow-up attempts are possible; No further information is expected.
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Axillary pain, Blood pressure measurement, Heart rate, Joint swelling, Peripheral swelling
Clinical narrative: my left elbow and forearm began to swell into a large ball shape near the elbow joint; my left hand became noticeably swollen as well; Swelling of the armpit, elbow and forearm areas; Swelling of the armpit, elbow and forearm areas; This is a spontaneous report from a contactable consumer. A 74-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: env201), via an unspecified route of administration, administered at left arm, on 24Feb2021 11:00 AM at single dose for COVID-19 immunisation. Patient medical history included allergies to sulfa based drugs. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included Amlodipine - 10mg. The patient stated that no prior reactions to the annual flu, pneumonia, or shingles vaccinations. Because of a scheduled prostate biopsy in early Apr2021, I wanted to complete the vaccination for COVID-19 in advance of this procedure. On 24Feb2021, within 5 mins of receiving the vaccination shot in my left arm, my left elbow and forearm began to swell into a large ball shape near the elbow joint. At the same time, patient's left hand became noticeably swollen as well. Fortunately, Patient did not experience trouble breathing or have any numbness in fingers at that time. The observation staff nurses took patient to a separate room to check blood pressure and heart rate which were both in the normal range. The patient also experienced swelling of the armpit, elbow and forearm areas are still present the next day. The patient received the treatment as Benadryl in response to the adverse events reduce swelling. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. The outcome for events was not recovered. No follow-up attempts are possible; No further information is expected.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Headache, Hyperthermia, Pain
Clinical narrative: After the 1st dose he was tested positive; After the 1st dose he was tested positive; This is a spontaneous report from a contactable consumer (patient) via a Pfizer sponsored program. A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 25Jan2021 as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced after the 1st dose he was tested positive on an unspecified date in 2021.  He asked if he needed to take the 2nd dose or if he needed to start again taking the 1st dose or if he needed to wait for 90 days before taking another vaccine. Outcome of the event was unknown.  Information on the lot/batch number has been requested.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 antibody test
Clinical narrative: After the 1st dose he was tested positive; After the 1st dose he was tested positive; This is a spontaneous report from a contactable consumer (patient) via a Pfizer sponsored program. A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 25Jan2021 as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced after the 1st dose he was tested positive on an unspecified date in 2021.  He asked if he needed to take the 2nd dose or if he needed to start again taking the 1st dose or if he needed to wait for 90 days before taking another vaccine. Outcome of the event was unknown.  Information on the lot/batch number has been requested.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Vomiting
Clinical narrative: Nausea; threw up bile; This is a spontaneous report from a contactable consumer (patient). A 35-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: EN6205), at 35 years of age, via an unspecified route of administration on 28Feb2021 11:00 at single dose, in left arm for COVID-19 immunisation. The patient medical history included hypothyroidism and patient had allergic reaction hives to Ceclor. Concomitant medication was not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: unknown), on unspecified date at single dose for COVID-19 immunisation. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not diagnosed with COVID-19 prior to vaccination. The patient had not tested positive for COVID-19 since having the vaccine. On 01Mar2021 03:00, the patient experienced nausea and threw up bile. The events were considered as non-serious. No treatment was given for the events. The outcome of the events was recovering.   No follow-up attempts are possible. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Duodenogastric reflux, Nausea
Clinical narrative: Nausea; threw up bile; This is a spontaneous report from a contactable consumer (patient). A 35-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: EN6205), at 35 years of age, via an unspecified route of administration on 28Feb2021 11:00 at single dose, in left arm for COVID-19 immunisation. The patient medical history included hypothyroidism and patient had allergic reaction hives to Ceclor. Concomitant medication was not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: unknown), on unspecified date at single dose for COVID-19 immunisation. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not diagnosed with COVID-19 prior to vaccination. The patient had not tested positive for COVID-19 since having the vaccine. On 01Mar2021 03:00, the patient experienced nausea and threw up bile. The events were considered as non-serious. No treatment was given for the events. The outcome of the events was recovering.   No follow-up attempts are possible. No further information is expected.